Self‐expandable sirolimus‐eluting stents compared to second‐generation drug‐eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS‐2 registries

To compare the effectiveness and safety of self‐expandable, sirolimus‐eluting Stentys stents (SES) and second‐generation drug‐eluting stents (DES‐II) for the treatment of the unprotected left main (ULM).

[1]  I. Elgendy,et al.  Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  F. Gaita,et al.  Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents. , 2017, The American journal of cardiology.

[3]  F. Gaita,et al.  Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study). , 2017, The American journal of cardiology.

[4]  F. Gaita,et al.  Three Arterial Grafts Improve Late Survival: A Meta-Analysis of Propensity-Matched Studies. , 2017, Circulation.

[5]  Alfredo E. Rodríguez,et al.  Can We Improve the Outcomes of Multivessel Disease Using Modified SYNTAX and Residual SYNTAX Scores? , 2017, Current Cardiology Reports.

[6]  P. Serruys,et al.  Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis , 2017, European heart journal cardiovascular Imaging.

[7]  M. Kacprzak,et al.  Self-expanding STENTYS stents in daily routine use. , 2017, Kardiologia polska.

[8]  J. Tijssen,et al.  Pre-hospital management, procedural performance and outcomes for primary percutaneous coronary intervention in ST-elevation myocardial infarction in the Netherlands: Insights from the Dutch cohort of the APPOSITION-III trial , 2016, Netherlands Heart Journal.

[9]  F. D’Ascenzo,et al.  Minding the gap between left main and branch vessels: Second-generation self-apposing, balloon-expandable, drug-eluting stent on trifurcated unprotected left main. , 2016, International journal of cardiology.

[10]  Shao-Liang Chen,et al.  Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: A propensity matched analysis. , 2016, International journal of cardiology.

[11]  L. Mariani,et al.  A real world single centre experience using the STENTYS self-expanding coronary stent. , 2016, International journal of cardiology.

[12]  J. Tijssen,et al.  First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[13]  R. V. van Geuns,et al.  STENTYS Self-Apposing sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[14]  D. Buccheri,et al.  Drug-eluting stent treatment of left main coronary artery disease: the case for a sirolimus-eluting, autoexpandable alternative. An optical coherence tomography analysis. , 2015, International journal of cardiology.

[15]  Michael Joner,et al.  Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014 , 2015, European heart journal.

[16]  C. Briguori,et al.  The STENTYS® paclitaxel‐eluting stent in the treatment of unprotected distal left main , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). , 2015, Circulation.

[18]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). , 2015, Journal of the American College of Cardiology.

[19]  T. Roleder,et al.  Treatment of left main coronary artery stenosis with the STENTYS self-expandable drug-eluting stent – a pilot registry , 2014, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

[20]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[21]  Jennifer Taylor.  Third universal definition of myocardial infarction. , 2012, European heart journal.

[22]  M. Budoff,et al.  Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients , 2012, Heart.

[23]  Patrick W Serruys,et al.  Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[24]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[25]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[26]  R. Erbel,et al.  Ten-year outcome after coronary angioplasty in patients with single-vessel coronary artery disease and comparison with the results of the Coronary Artery Surgery Study (CASS). , 2000, The American journal of cardiology.